Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/09/2026 ,inter alia, to consider and approve To consider approve the proposal for raising funds through the issuance of equity shares, warrants convertible into equity shares, or other permitted instruments by way of preferential issue, private placement, rights issue or any combination.
Aspira Pathlab & Diagnostics Ltd. Press Release Sep 07 2026
Earlier from Aspira Pathlab & Diagnostics
- Aspira Pathlab & Diagnostics Ltd. Press Release Sep 05 2026
- Aspira Pathlab & Diagnostics Ltd. Press Release Sep 03 2026
- Aspira Pathlab & Diagnostics Ltd. Press Release Sep 01 2026
- Aspira Pathlab & Diagnostics Ltd. Press Release Aug 31 2026
